Story thread · 2 reports / 2 sources
Fresenius Warned by FDA Over Violations at Illinois Facility
bloomberg.com · 3h · first report
Fresenius SE’s generic drugs unit Kabi received a warning letter from the US Food and Drug Administration citing “significant violations” at a facility in Illinois.
The coverage
- Fresenius Kabi hit with warning letter over conditions at Illinois facility
seekingalpha.com · 3h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.